PUMA BIOTECHNOLOGY, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PUMA BIOTECHNOLOGY, INC. (PBYI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.95M, a 19.96% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.90M, a 6.42% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $1.62M, a 7.71% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.67M, a 18.55% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $6.94M, a 15.78% decline from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $8.24M, a 19.54% decline from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $10.25M, a 13.35% decline from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $11.83M, a 63.76% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 8 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.95M 10-Q · filed 2026-08-06 | $3.85M 10-Q · filed 2026-08-06 | $5.47M derived: sum of 3 quarters · filed 2026-08-06 | $7.14M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-07 | $3.51M derived: sum of 2 quarters · filed 2026-05-07 | $5.19M derived: sum of 3 quarters · filed 2026-05-07 | $6.81M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.29M derived: sum of 2 quarters · filed 2026-02-26 | $4.92M derived: sum of 3 quarters · filed 2026-08-06 | $6.94M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $1.67M 10-Q · filed 2025-11-06 | $3.30M derived: sum of 2 quarters · filed 2026-08-06 | $5.33M 10-Q · filed 2025-11-06 | $7.08M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $1.63M 10-Q · filed 2026-08-06 | $3.65M 10-Q · filed 2026-08-06 | $5.41M derived: sum of 3 quarters · filed 2026-08-06 | $7.46M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $2.03M 10-Q · filed 2026-05-07 | $3.78M derived: sum of 2 quarters · filed 2026-05-07 | $5.83M derived: sum of 3 quarters · filed 2026-05-07 | $7.89M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.81M derived: sum of 2 quarters · filed 2026-02-26 | $5.87M derived: sum of 3 quarters · filed 2026-02-26 | $8.24M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $2.05M 10-Q · filed 2025-11-06 | $4.12M derived: sum of 2 quarters · filed 2025-11-06 | $6.49M 10-Q · filed 2025-11-06 | $8.93M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $2.06M 10-Q · filed 2025-08-07 | $4.44M 10-Q · filed 2025-08-07 | $6.87M derived: sum of 3 quarters · filed 2026-02-26 | $9.42M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $2.38M 10-Q · filed 2025-05-08 | $4.81M derived: sum of 2 quarters · filed 2026-02-26 | $7.35M derived: sum of 3 quarters · filed 2026-02-26 | $9.79M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.98M derived: sum of 2 quarters · filed 2026-02-26 | $7.41M derived: sum of 3 quarters · filed 2026-02-26 | $10.25M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $2.54M 10-Q · filed 2024-11-07 | $4.98M derived: sum of 2 quarters · filed 2024-11-07 | $7.82M 10-Q · filed 2024-11-07 | $10.44M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $2.43M 10-Q · filed 2024-08-01 | $5.27M 10-Q · filed 2024-08-01 | $7.90M derived: sum of 3 quarters · filed 2025-02-27 | $10.73M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $2.84M 10-Q · filed 2024-05-02 | $5.47M derived: sum of 2 quarters · filed 2025-02-27 | $8.30M derived: sum of 3 quarters · filed 2025-02-27 | $11.52M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.46M derived: sum of 2 quarters · filed 2025-02-27 | $8.68M derived: sum of 3 quarters · filed 2025-02-27 | $11.83M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $2.83M 10-Q · filed 2023-11-02 | $6.05M derived: sum of 2 quarters · filed 2023-11-02 | $9.20M 10-Q · filed 2023-11-02 | $13.45M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $3.22M 10-Q · filed 2023-08-03 | $6.37M 10-Q · filed 2023-08-03 | $10.62M derived: sum of 3 quarters · filed 2024-02-29 | $14.90M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $3.15M 10-Q · filed 2023-05-04 | $7.40M derived: sum of 2 quarters · filed 2024-02-29 | $11.68M derived: sum of 3 quarters · filed 2024-02-29 | $29.92M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $8.53M derived: sum of 2 quarters · filed 2024-02-29 | $26.77M derived: sum of 3 quarters · filed 2024-02-29 | $32.63M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $4.28M 10-Q · filed 2022-11-03 | $22.52M derived: sum of 2 quarters · filed 2022-11-03 | $28.38M 10-Q · filed 2022-11-03 | $37.85M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-06-30 | $18.24M 10-Q · filed 2022-08-04 | $24.10M 10-Q · filed 2022-08-04 | $33.57M derived: sum of 3 quarters · filed 2023-03-02 | $41.14M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2021-03-31 | $5.86M 10-Q · filed 2022-05-05 | $15.33M derived: sum of 2 quarters · filed 2023-03-02 | $22.90M derived: sum of 3 quarters · filed 2023-03-02 | $33.53M derived: sum of 4 quarters · filed 2023-03-02 | ||
| 2020-12-31 | $9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $17.04M derived: sum of 2 quarters · filed 2023-03-02 | $27.67M derived: sum of 3 quarters · filed 2023-03-02 | $36.58M 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $7.57M 10-Q · filed 2021-11-04 | $18.20M derived: sum of 2 quarters · filed 2021-11-04 | $27.10M 10-Q · filed 2021-11-04 | $38.64M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-06-30 | $10.63M 10-Q · filed 2021-08-05 | $19.54M 10-Q · filed 2021-08-05 | $31.07M derived: sum of 3 quarters · filed 2022-03-03 | $43.29M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2020-03-31 | $8.91M 10-Q · filed 2021-05-06 | $20.44M derived: sum of 2 quarters · filed 2022-03-03 | $32.66M derived: sum of 3 quarters · filed 2022-03-03 | $48.10M derived: sum of 4 quarters · filed 2022-03-03 | ||
| 2019-12-31 | $11.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $23.75M derived: sum of 2 quarters · filed 2022-03-03 | $39.19M derived: sum of 3 quarters · filed 2022-03-03 | $57.33M 10-K · filed 2022-03-03 | ||
| 2019-09-30 | $12.21M 10-Q · filed 2020-11-05 | $27.65M derived: sum of 2 quarters · filed 2020-11-05 | $45.79M 10-Q · filed 2020-11-05 | $64.39M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $15.44M 10-Q · filed 2020-08-06 | $33.58M 10-Q · filed 2020-08-06 | $52.17M derived: sum of 3 quarters · filed 2021-03-01 | $72.98M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $18.14M 10-Q · filed 2020-05-07 | $36.73M derived: sum of 2 quarters · filed 2021-03-01 | $57.54M derived: sum of 3 quarters · filed 2021-03-01 | $79.72M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $18.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $39.40M derived: sum of 2 quarters · filed 2021-03-01 | $61.59M derived: sum of 3 quarters · filed 2021-03-01 | $86.94M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $20.81M 10-Q · filed 2019-11-07 | $42.99M derived: sum of 2 quarters · filed 2019-11-07 | $68.34M 10-Q · filed 2019-11-07 | $93.86M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $22.18M 10-Q · filed 2019-08-09 | $47.54M 10-Q · filed 2019-08-09 | $73.06M derived: sum of 3 quarters · filed 2020-02-28 | $99.55M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $25.35M 10-Q · filed 2019-05-10 | $50.87M derived: sum of 2 quarters · filed 2020-02-28 | $77.36M derived: sum of 3 quarters · filed 2020-02-28 | $104.32M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $25.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $52.01M derived: sum of 2 quarters · filed 2020-02-28 | $78.97M derived: sum of 3 quarters · filed 2020-02-28 | $108.73M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $26.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $53.45M derived: sum of 2 quarters · filed 2017-11-09 | $83.21M 10-Q · filed 2017-11-09 | $112.49M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $26.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $56.72M 10-Q · filed 2017-08-09 | $86.00M derived: sum of 3 quarters · filed 2019-03-01 | $115.75M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $29.76M 10-Q · filed 2017-05-10 | $59.04M derived: sum of 2 quarters · filed 2019-03-01 | $88.79M derived: sum of 3 quarters · filed 2019-03-01 | $117.52M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $29.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $59.02M derived: sum of 2 quarters · filed 2019-03-01 | $87.75M derived: sum of 3 quarters · filed 2019-03-01 | $117.26M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $29.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $58.48M derived: sum of 2 quarters · filed 2016-11-09 | $87.99M 10-Q · filed 2016-11-09 | $109.67M derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-06-30 | $28.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $58.24M 10-Q · filed 2016-08-09 | $79.92M derived: sum of 3 quarters · filed 2018-03-09 | $104.88M derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-03-31 | $29.51M 10-Q · filed 2016-05-10 | $51.19M derived: sum of 2 quarters · filed 2018-03-09 | $76.15M derived: sum of 3 quarters · filed 2018-03-09 | $104.34M derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2015-12-31 | $21.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $46.64M derived: sum of 2 quarters · filed 2018-03-09 | $74.83M derived: sum of 3 quarters · filed 2018-03-09 | $94.93M 10-K · filed 2018-03-09 | ||
| 2015-09-30 | $24.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $53.15M derived: sum of 2 quarters · filed 2015-11-09 | $73.25M 10-Q · filed 2015-11-09 | $89.63M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $28.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $48.30M 10-Q · filed 2015-08-10 | $64.67M derived: sum of 3 quarters · filed 2017-03-01 | $75.12M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $20.10M 10-Q · filed 2015-05-11 | $36.48M derived: sum of 2 quarters · filed 2017-03-01 | $46.92M derived: sum of 3 quarters · filed 2017-03-01 | $54.09M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $16.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $26.82M derived: sum of 2 quarters · filed 2017-03-01 | $33.99M derived: sum of 3 quarters · filed 2017-03-01 | $39.15M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $10.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $17.62M derived: sum of 2 quarters · filed 2014-11-10 | $22.78M 10-Q · filed 2014-11-10 | $25.87M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $7.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $12.33M 10-Q · filed 2014-08-11 | $15.42M derived: sum of 3 quarters · filed 2016-02-29 | $17.23M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $5.16M 10-Q · filed 2014-05-12 | $8.26M derived: sum of 2 quarters · filed 2016-02-29 | $10.06M derived: sum of 3 quarters · filed 2016-02-29 | $11.51M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $4.90M derived: sum of 2 quarters · filed 2016-02-29 | $6.34M derived: sum of 3 quarters · filed 2016-02-29 | $7.52M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $3.25M derived: sum of 2 quarters · filed 2013-11-12 | $4.43M 10-Q · filed 2013-11-12 | $5.01M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $2.62M 10-Q · filed 2013-08-06 | $3.21M derived: sum of 3 quarters · filed 2015-03-02 | $3.57M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | $1.18M 10-Q · filed 2013-05-09 | $1.76M derived: sum of 2 quarters · filed 2015-03-02 | $2.12M derived: sum of 3 quarters · filed 2015-03-02 | $2.38M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2012-12-31 | $587.95K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $946.23K derived: sum of 2 quarters · filed 2015-03-02 | $1.21M derived: sum of 3 quarters · filed 2015-03-02 | $1.41M 10-K · filed 2015-03-02 | ||
| 2012-09-30 | $358.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $621.99K derived: sum of 2 quarters · filed 2012-11-14 | $820.05K 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | $263.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $461.77K 10-Q · filed 2012-08-14 | ||||
| 2012-03-31 | $198.06K 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | $67.00K 10-Q · filed 2014-11-10 | $67.02K 10-K · filed 2012-03-29 | ||||
| 2011-06-30 | $8.20K 10-Q · filed 2011-08-15 | |||||
| 2010-12-31 | $16.30K 10-Q · filed 2011-08-15 | |||||
| 2009-12-31 | $19.15K 10-Q · filed 2011-08-15 | |||||
| 2008-12-31 | $10.50K 10-Q · filed 2011-08-15 | |||||
| 2007-12-31 | $4.50K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |